SAN DIEGO--(BUSINESS WIRE)--Today, CRISPR QC announces that Paragraf, Ltd. has acquired Cardea Bio, the technology platform developer of the CRISPR-Chip - a graphene-based biosensor that powers CRISPR ...
KIRKLAND, Wash.--(BUSINESS WIRE)--Cardiac Insight, a U.S. developer of body worn sensing devices and computational software, announced today, the FDA has cleared the company’s wearable ...
ORLANDO, FL and ATLANTA, GA, Aug. 17, 2023 (GLOBE NEWSWIRE) -- Global Blockchain Acquisition Corp. (NASDAQ: GBBK) (“GBBK”), a publicly traded special purpose acquisition company, and Cardea Corporate ...
SAN DIEGO, Aug. 16, 2022 /PRNewswire/ --Since its founding in late 2013, Cardea's scientists have been pioneering the development of the world's first mass produced biocompatible semiconductor - the ...
San Diego-based Cardea Bio, which is integrating biology with modern electronics, said today it has received a $1.1 million grant from the Bill & Melinda Gates Foundation to fund work that someday ...